GILEAD SCIENCES, INC. Q4 2025 Filing
Filed February 12, 2026
Portfolio Value
$1.9T
Holdings
6
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (6 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCUSARCUS BIOSCIENCES INC | 31,424,760 | $748.9B | 38.69% | |
| 2 | GLPGGALAPAGOS NV | 16,707,477 | $550.6B | 28.45% | |
| 3 | ACLXARCELLX INC | 6,720,803 | $438.2B | 22.64% | |
| 4 | ASMBASSEMBLY BIOSCIENCES INC | 4,505,391 | $153.2B | 7.92% | |
| 5 | KYTXKYVERNA THERAPEUTICS INC | 4,126,119 | $38.8B | 2.00% | |
| 6 | XLOXILIO THERAPEUTICS INC | 9,105,451 | $5.8B | 0.30% |